Thomas C. Freyman's most recent trade in Abbvie Inc was a trade of 1,118 Common Stock, $0.01 par value done . Disclosure was reported to the exchange on May 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AbbVie | Thomas C. Freyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2026 | 1,118 | 127,869 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Thomas C. Freyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 1,203 | 126,751 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Thomas C. Freyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 1,322 | 125,548 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Thomas C. Freyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 1,450 | 124,226 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Thomas C. Freyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 1,421 | 122,776 (0%) | 0% | 0 | Common Stock, $0.01 par value |